Table 1.
Diet | LM | HM | SEM | p Value | ||||
---|---|---|---|---|---|---|---|---|
PYCW | 0% | 0.2% | 0% | 0.2% | Diet | PYCW | Diet vs. PYCW | |
Body weight, kg | ||||||||
d 0 | 7.45 | 7.49 | 7.51 | 7.53 | 0.48 | 0.659 | 0.784 | 0.939 |
d 7 | 10.11 | 9.82 | 9.33 | 9.60 | 0.69 | 0.016 | 0.970 | 0.168 |
d 14 | 13.73 | 13.65 | 12.47 | 12.94 | 0.85 | 0.005 | 0.567 | 0.418 |
d 21 | 17.57 | 17.71 | 15.76 | 16.24 | 0.93 | <0.001 | 0.475 | 0.692 |
d 28 | 22.39 | 22.31 | 19.79 | 20.32 | 1.29 | <0.001 | 0.697 | 0.598 |
d 36 | 29.49 | 29.43 | 25.74 | 26.47 | 1.47 | <0.001 | 0.632 | 0.574 |
ADG, kg | ||||||||
Phase 1 (d 0 to 7) | 0.379 a | 0.333 | 0.261 b | 0.296 | 0.039 | 0.001 | 0.815 | 0.081 |
Phase 2 (d 7 to 21) | 0.533 | 0.563 | 0.459 | 0.474 | 0.024 | 0.001 | 0.346 | 0.750 |
d 7 to 14 | 0.518 | 0.547 | 0.449 | 0.476 | 0.031 | 0.017 | 0.320 | 0.980 |
d 14 to 21 | 0.549 | 0.580 | 0.470 | 0.472 | 0.038 | 0.018 | 0.667 | 0.708 |
Phase 3 (d 21 to 36) | 0.794 | 0.781 | 0.665 | 0.682 | 0.039 | <0.001 | 0.938 | 0.553 |
d 21 to 28 | 0.688 | 0.657 | 0.576 | 0.584 | 0.055 | 0.005 | 0.714 | 0.545 |
d 28 to 36 | 0.887 | 0.890 | 0.743 | 0.768 | 0.031 | <0.001 | 0.624 | 0.693 |
Overall (d 0 to 36) | 0.612 | 0.609 | 0.506 | 0.526 | 0.029 | <0.001 | 0.647 | 0.547 |
ADFI, kg | ||||||||
Phase 1 (d 0 to 7) | 0.310 | 0.315 | 0.239 | 0.246 | 0.040 | 0.002 | 0.765 | 0.972 |
Phase 2 (d 7 to 21) | 0.651 | 0.700 | 0.559 | 0.594 | 0.039 | 0.002 | 0.170 | 0.817 |
d 7 to 14 | 0.622 | 0.679 | 0.519 | 0.551 | 0.047 | <0.001 | 0.156 | 0.689 |
d 14 to 21 | 0.681 | 0.721 | 0.599 | 0.636 | 0.040 | 0.040 | 0.334 | 0.972 |
Phase 3 (d 21 to 36) | 1.112 | 1.129 | 0.947 | 1.014 | 0.067 | <0.001 | 0.253 | 0.491 |
d 21 to 28 | 0.922 | 0.930 | 0.790 | 0.805 | 0.071 | 0.003 | 0.768 | 0.941 |
d 28 to 36 | 1.279 | 1.302 | 1.084 | 1.196 | 0.069 | 0.002 | 0.130 | 0.319 |
Overall (d 0 to 36) | 0.777 | 0.804 | 0.658 | 0.701 | 0.048 | <0.001 | 0.191 | 0.764 |
G/F | ||||||||
Phase 1 (d 0 to 7) | 1.25 | 1.06 b | 1.11 Y | 1.40 aX | 0.13 | 0.381 | 0.627 | 0.031 |
Phase 2 (d 7 to 21) | 0.82 | 0.81 | 0.83 | 0.81 | 0.03 | 0.963 | 0.593 | 0.825 |
d 7 to 14 | 0.83 | 0.82 | 0.87 | 0.87 | 0.04 | 0.057 | 0.882 | 0.726 |
d 14 to 21 | 0.81 | 0.80 | 0.79 | 0.75 | 0.05 | 0.425 | 0.557 | 0.776 |
Phase 3 (d 21 to 36) | 0.72 | 0.70 | 0.70 | 0.68 | 0.02 | 0.283 | 0.164 | 0.996 |
d 21 to 28 | 0.75 | 0.71 | 0.73 | 0.72 | 0.02 | 0.842 | 0.284 | 0.368 |
d 28 to 36 | 0.70 | 0.69 | 0.69 | 0.65 | 0.03 | 0.253 | 0.286 | 0.616 |
Overall (d 0 to 36) | 0.79 | 0.76 | 0.77 | 0.76 | 0.02 | 0.296 | 0.056 | 0.507 |
There was no animal mortality during the experimental period. 1 HM has 1.0 μg/kg of aflatoxin B1 (AFB1) and 2258 μg/kg of deoxynivalenol (DON) on average for phases 1 and 2, and 44.6 μg/kg of AFB1 and 4635 μg/kg of DON for phase 3. a,b Means with different superscripts differ (p < 0.05). X,Y Means with different superscripts tend to differ (0.05 ≤ p < 0.10).